Published in Lab Invest on January 01, 1991
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev (1998) 2.48
A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol (1996) 2.29
The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol (1995) 1.83
Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am J Pathol (1998) 1.46
A locus on chromosome 7 determines myocardial cell necrosis and calcification (dystrophic cardiac calcinosis) in mice. Proc Natl Acad Sci U S A (1996) 1.15
Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis. J Virol (1996) 1.11
Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest (2002) 1.09
Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site. J Virol (2006) 1.08
Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin. Immunology (1998) 1.01
Verapamil ameliorates the clinical and pathological course of murine myocarditis. J Clin Invest (1992) 1.01
Autoimmune myocarditis induced in mice by cardiac C-protein. Cloning of complementary DNA encoding murine cardiac C-protein and partial characterization of the antigenic peptides. J Clin Invest (1994) 0.99
Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line. J Virol (2011) 0.96
An aged host promotes the evolution of avirulent coxsackievirus into a virulent strain. Proc Natl Acad Sci U S A (2006) 0.91
TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4. Am J Physiol Regul Integr Comp Physiol (2012) 0.82
Characterization of coxsackievirus B3-caused apoptosis under in vitro conditions. Med Microbiol Immunol (2003) 0.80
Profiling Subcellular Protein Phosphatase Responses to Coxsackievirus B3 Infection of Cardiomyocytes. Mol Cell Proteomics (2017) 0.79
Coxsackievirus B3-induced myocarditis: differences in the immune response of C57BL/6 and Balb/c mice. Med Microbiol Immunol (2003) 0.78
Mapping of a quantitative trait locus controlling susceptibility to Coxsackievirus B3-induced viral hepatitis. Genes Immun (2015) 0.75
A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med (1995) 6.14
Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridization. J Clin Microbiol (1990) 3.75
The autopsy and the public need. Can medicine respond? Arch Pathol Lab Med (1994) 2.59
Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. J Med Virol (1979) 1.94
Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol (2001) 1.91
Isolated pulmonic valve infective endocarditis: a diagnostically elusive entity. Am Heart J (1985) 1.86
Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha. J Mol Cell Cardiol (2001) 1.63
Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol (1987) 1.58
Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab Invest (1992) 1.57
Transcription of the genomes of type 1 and type 3 reoviruses. J Virol (1968) 1.56
Echovirus 22 is an atypical enterovirus. J Virol (1990) 1.55
Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol (1989) 1.50
Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc Natl Acad Sci U S A (1992) 1.49
Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes (2000) 1.46
The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology (2000) 1.46
Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J Virol (1998) 1.41
An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch Virol (1994) 1.40
Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol (1993) 1.32
Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans. FASEB J (2001) 1.29
Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus. Mol Cell Biochem (2001) 1.27
Intestinal cryptosporidiosis complicated by disseminated cytomegalovirus infection. Gastroenterology (1981) 1.27
Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue. J Immunol (1978) 1.27
Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains. J Virol (1984) 1.26
Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets. J Virol (1996) 1.22
Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. J Med Virol (2000) 1.19
Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis. J Immunol (1986) 1.18
Reovirus-induced ribonucleic acid polymerase. J Virol (1968) 1.17
An encephalomyocarditis virus epizootic in a baboon colony. Lab Anim Sci (1992) 1.16
Localization of aortic disease is associated with intrinsic differences in aortic structure. J Surg Res (1995) 1.15
Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity. Adv Virus Res (1998) 1.15
Fragmentation of RNA in virus particles of rhinovirus type 14. J Virol (1974) 1.15
Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists. J Heart Lung Transplant (1996) 1.12
Rapid cytochrome c release, activation of caspases 3, 6, 7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy. FEBS Lett (1998) 1.12
Isolation of Coxsackievirus B3 temperture-sensitive mutants and their assignment to complementation groups. Biochem Biophys Res Commun (1976) 1.11
Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis. J Virol (1996) 1.11
Apoptosis: molecular aspects of cell death and disease. Lab Invest (1998) 1.11
Inhibition of Mengo virus by interferon. J Bacteriol (1966) 1.10
Murine natural killer cells limit coxsackievirus B3 replication. J Immunol (1987) 1.10
Modification of viral myocarditis in mice by interleukin-6. Circ Res (1996) 1.10
Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor. Virology (1998) 1.10
Anomalous drainage of the inferior vena cava into a left atrial connection: a case report involving a 41-year-old man. Cathet Cardiovasc Diagn (1989) 1.08
In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis. Am J Pathol (1987) 1.08
Host gene regulation during coxsackievirus B3 infection in mice: assessment by microarrays. Circ Res (2000) 1.07
Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication. J Virol (1999) 1.07
Fractionation and immunologic assessment of KCl-extracted cardiac antigens in coxsackievirus B3 virus-induced myocarditis. J Immunol (1979) 1.06
A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J Mol Cell Cardiol (1990) 1.05
BNips: a group of pro-apoptotic proteins in the Bcl-2 family. Apoptosis (2003) 1.05
Synthesis of ribonucleic acids in KB cells infected with rhinovirus type 14. J Gen Virol (1973) 1.05
Advances in experimental dyslipidemia and atherosclerosis. Lab Invest (2001) 1.04
Assessment of cell-mediated immunity against coxsackievirus B3-induced myocarditis in a primate model (Papio papio). Infect Immun (1981) 1.04
Secondary enterovirus infection in the murine model of myocarditis. Pathologic and immunologic aspects. Am J Pathol (1990) 1.04
Juvenile polysaccharidosis with cardioskeletal myopathy. Arch Pathol Lab Med (1987) 1.04
Properties and origins of infectious rhinovirus type 14 particles of different buoyant densities. J Virol (1975) 1.03
Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model. Infect Immun (1979) 1.02
Human transplant coronary artery disease: pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy. Lab Invest (1996) 1.01
Release of cytochrome c, Bax migration, Bid cleavage, and activation of caspases 2, 3, 6, 7, 8, and 9 during endothelial cell apoptosis. Am J Pathol (1999) 1.01
Viral myocarditis: identification of five differentially expressed genes in coxsackievirus B3-infected mouse heart. Circ Res (1999) 1.01
Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis. Circulation (1999) 1.01
Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin. Blood (2000) 0.99
Immunoreactivity of anti-streptococcal monoclonal antibodies to human heart valves. Evidence for multiple cross-reactive epitopes. Am J Pathol (1991) 0.99
Structural and functional analysis of the 5' untranslated region of coxsackievirus B3 RNA: In vivo translational and infectivity studies of full-length mutants. Virology (1999) 0.99
Destruction of L cells by Mengo virus: use of interferon to study the mechanism. J Virol (1968) 0.99
Bcl-2 overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy. Br J Cancer (1999) 0.95
Age-related changes in naive and memory CD4+ T cells in healthy human children. Clin Immunol Immunopathol (1989) 0.95
Phenotypic analysis of infiltrating cells in human myocarditis. An immunohistochemical study in paraffin-embedded tissue. Arch Pathol Lab Med (1989) 0.95
Ameliorating effect of IFN-beta and anti-IFN-beta on coxsackievirus B3-induced myocarditis in mice. J Interferon Res (1985) 0.95
Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice: possible mechanisms of action. Circulation (1999) 0.94
Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis. Infect Immun (1983) 0.94
Levamisole exacerbates coxsackievirus B3-induced murine myocarditis. Infect Immun (1983) 0.93
The case for preoperative coronary angiography in patients with tetralogy of Fallot and other complex congenital heart diseases. Am Heart J (1982) 0.93
Early degradation of collagen after acute myocardial infarction in the rat. Am J Cardiol (1983) 0.93
Autoimmune determinants of rheumatic carditis: localization of epitopes in human cardiac myosin. Eur Heart J (1991) 0.93
Allograft inflammatory factory-1. A cytokine-responsive macrophage molecule expressed in transplanted human hearts. Transplantation (1996) 0.93
Fatal dissection of the pulmonary trunk. An obscure consequence of chronic pulmonary hypertension. Am J Cardiovasc Pathol (1988) 0.93
The Myocarditis Treatment Trial: design, methods and patients enrollment. Eur Heart J (1995) 0.92
Immunohistochemical characterization of lymphocytes in uninflamed ventricular myocardium. Implications for myocarditis. Arch Pathol Lab Med (1985) 0.92
Fatal cardiac strangulation by congenital partial pericardial defect. Am Heart J (1984) 0.92
Fragility of the rhinovirus type 14 genome to incubation at 60 degrees. Intervirology (1980) 0.92
Elongate thrombus extending from left ventricular apex to outflow tract: a rare complication of myocardial infarction diagnosed by two-dimensional echocardiography. Am Heart J (1983) 0.91
Status of the major epicardial coronary arteries 80 to 150 days after percutaneous transluminal coronary angioplasty. Analysis of 3 necropsy patients. Am J Cardiol (1983) 0.91
Sigmoidity of the ventricular septum revisited: progression in early adulthood, predominance in men, and independence from cardiac mass. Am J Cardiovasc Pathol (1988) 0.90
Immunopathologic basis of myocardial injury. Cardiovasc Clin (1988) 0.90
Neonatal intima formation in the human coronary artery. Arterioscler Thromb Vasc Biol (1999) 0.90
Posttransplant obesity and hyperlipidemia: major predictors of severity of coronary arteriopathy in failed human heart allografts. J Heart Transplant (1990) 0.90
Interaction of viral proteins with host cell death machinery. Cell Death Differ (1998) 0.89
Molecular studies on enteroviral heart disease: patterns of acute and persistent infections. Eur Heart J (1991) 0.89
Effect of interferon on synthesis of ssRNA in reovirus type 3-infected L cell cultures. Biochem Biophys Res Commun (1972) 0.88
Fas ligand and TRAIL augment the effect of photodynamic therapy on the induction of apoptosis in JURKAT cells. Int Immunopharmacol (2001) 0.88
Successful treatment of heart transplant rejection with photopheresis. Transplantation (1992) 0.88
Serpina3n attenuates granzyme B-mediated decorin cleavage and rupture in a murine model of aortic aneurysm. Cell Death Dis (2011) 0.88
Biglycan, decorin, and versican protein expression patterns in coronary arteriopathy of human cardiac allograft: distinctness as compared to native atherosclerosis. J Heart Lung Transplant (1996) 0.88
Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background. Arch Intern Med (1997) 0.87
Detection of enteroviruses in cell cultures by using in situ transcription. J Clin Microbiol (1992) 0.87
Susceptibility to Coxsackievirus B3-induced chronic myocarditis maps near the murine Tcr alpha and Myhc alpha loci on chromosome 14. Am J Pathol (1991) 0.87
Preferential endocardial residence of B-cells in the "Quilty effect" of human heart allografts: immunohistochemical distinction from rejection. Mod Pathol (1991) 0.87
Giant cell arteritis of the legs. Clinical isolation of severe disease with gangrene and amputations. Am J Med (1986) 0.87